Fig. 1 · Structure

Documents & Downloads

HYNIC-iPSMA TFA

Tumor Molecular Ligand

HYNIC-iPSMA TFA is a ligand designed for targeted molecular imaging of tumors, specifically leveraging its activity against prostate-specific membrane antigen (PSMA). Comprising 6-hydrazinonicotinamide (HYNIC) for the attachment of radioactive isotopes and the specific inhibitor iPSMA, this compound facilitates the detection of prostate cancer through PET imaging using 68Ga-labeled isotopes. Additionally, the 99mTc-EDDA/HYNIC-iPSMA TFA conjugate demonstrates high specificity and sensitivity, making it a valuable tool for the synthesis and research of radionuclide-drug conjugates (RDCs) in cancer diagnostics.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Ligand / Binder
CAS Number 2375849-11-7
Applications Tumor Molecular Ligand
Formula C33H38F3N7O11
Molecular Weight 765.69
SMILES
C(C(O)=O)(F)(F)F.C([C@H](NC(=O)C=1C=CC(=NN)NC1)C(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)C2=CC3=C(C=C2)C=CC=C3

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...